Not reported
Active13747076Private limited companyLondon
LYRA PHARMA LIMITED
Significant control: Ian Jacobson (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Lyra Pharma Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Lyra Pharma Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
LYRA PHARMA LIMITED is an active private limited company (company number 13747076) incorporated on 16 November 2021, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2024 and cash of £173k, with 0 employees on average.
There are 603 companies in research and experimental development on biotechnology in London with filed accounts; the median reports net assets of £440 and is 6 years old.
02
Ownership and control
- Mr Ian Jacobson
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 16 November 20214 yrs ago
- Next accounts due
- 30 September 202624 days overdue
- Confirmation statement due
- 30 November 2026in 37 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£173k
−77%vs Dec 2023Not reported
0
vs Dec 2023| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2024 | — | £173k | £16k | £504k | — | — | 0 |
| 31 December 2023 | — | £758k | £196k | £1.23m | — | — | 0 |
Current ratio0.38Current assets ÷ creditors within one year
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Current assets below creditors within one yearCurrent ratio 0.38
- Cash at bank of £50,000 or moreCash £173,265
- Incorporated two to five years agoIncorporated 16 November 2021
- Accounts past their due dateDue 30 September 2026
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 37 days
- Next accounts due24 days overdue
- Accounts period end
- Accounts period end
- Incorporated
08
Similar companies in London
- TRIPLE HELIX BIOTECHNOLOGY LTDLondon · inc. Nov 2021
- MENDEA TECHNOLOGIES LIMITEDLondon · inc. Nov 2021
- CONSTRUCTIVE BIOLOGY LIMITEDLondon · inc. Nov 2021
- SANIA TX LTDLondon · inc. Nov 2021
- LIBERUM HEALTH LTDLondon · inc. Nov 2021
- UK NIVD LTDLondon · inc. Nov 2021
All companies incorporated on 16 November 2021 · in Nov 2021.
09
Reminders for LYRA PHARMA LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.